Agilent SureSelect Human All Exon kit
20 November, 2009 | Agilent Technologies Australia Pty Ltd
The SureSelect Human All Exon Kit for the Applied Biosystems SOLiD System enables target enrichment prior to next-generation DNA sequencing.
PerkinElmer AutomatedGSP Genetic Screening Processor
20 November, 2009 | PerkinElmer (Australia) Pty Ltd
PerkinElmer has received the first 510(k) clearance from the US Food and Drug Administration for its automated GSP Genetic Screening Processor, used by public health laboratories as part of newborn screening programs.
Biomatrica/Qiagen QIAsafe DNA blood products
20 November, 2009 | QIAGEN Pty Ltd
Biomatrica and Qiagen have launched QIAsafe DNA Blood Products, the first dry blood storage available on a matrix based on Biomatrica’s SampleMatrix technology.
Venom Science Cobra Venom Detection Kit
20 November, 2009 | Venom Supplies Pty Ltd
Venom Science has developed a Cobra Venom Detection Kit to assist in tracing the illegal use of cobra venom by racing trainers, previously difficult to detect. The test involves using specially treated venom antibodies which are labelled with markers that highlight the cobra venom when they come into contact with it.
Bio-Rad acquires Biotest diagnostics
20 November, 2009 | Bio-Rad Laboratories
Bio-Rad Laboratories has signed an agreement to acquire certain diagnostic businesses of Biotest for 45 million euros, the terms of which were not disclosed. The transaction is subject to closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2010.
Applied Biosystems SOLiD 3 Plus genomic analysis platform
20 November, 2009 | Life Technologies
Applied Biosystems’ SOLiD 3 Plus System, a genomic analysis platform, is designed for users working towards mainstream sequencing of personal genomes for clinical research and personalised medicine.
Labofix fixed volume micropipettes
20 November, 2009 | Sieper & Co Pty Ltd
Labofix fixed volume micropipettes complete the adjustable volume Pluripet ll range and 10 models offer a choice of volume range from 5 to 1000 µL.
SensiGene Cystic Fibrosis (CF) Carrier Screening Test
20 November, 2009 | Agena Bioscience Inc
The SensiGene Cystic Fibrosis (CF) Carrier Screening Test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG).
Bruker maXis, ultrafleXtreme, amaZon and solariX
20 November, 2009 | Bruker Pty Ltd
Bruker Daltonics has released its latest life science mass spectrometry tools.
Lonza Potelligent CHOK1SV host cell line
20 November, 2009 | Capsugel Australia Pty Ltd
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
Greiner Bio-One Datamatrix Barcode Cryovials
20 November, 2009 | Interpath Services Pty Ltd
Greiner Bio-One has introduced 2D Datamatrix Cryovials for simple and accurate sample identification.
Enzo CELLestial fluorescent probes and labelling reagents
20 November, 2009 | Sapphire Bioscience
Enzo Life Sciences’ CELLestial fluorescent probes and labelling reagents for live cell analysis applications include reagents for detection of pH, calcium, chloride, zinc, membrane potential, ROS, GPCR, amyloid and lipid droplets.
Greiner Bio-One tissue culture range
20 November, 2009 | Interpath Services Pty Ltd
Greiner Bio-One’s tissue culture products include flasks, dishes, bottles, tubes and plates. Advanced tissue culture treatments are also available.
Shimadzu Scientific Instruments PTM Finder software
20 November, 2009 | Shimadzu Scientific Instruments (Oceania) Pty Ltd
PTM Finder software uses data mining to investigate post-translational modification in complex protein samples, including data for hypothetical, novel modifications. The software is designed to integrate with the Axima range of Maldi mass spectrometers.
Millipore FlowCellect kits
20 November, 2009 | Merck Pty Limited
Three FlowCellect kits are now available for benchtop flow cytometry, targeted at key signalling pathways and said to provide the first complete validation for evaluating complex cell signalling events without sending samples to a core laboratory.
